591 related articles for article (PubMed ID: 3397592)
41. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.
Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET
Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974
[TBL] [Abstract][Full Text] [Related]
42. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
[TBL] [Abstract][Full Text] [Related]
44. Erythropoietin therapy in patients with chronic renal failure.
Pinevich AJ; Petersen J
West J Med; 1992 Aug; 157(2):154-7. PubMed ID: 1441466
[TBL] [Abstract][Full Text] [Related]
45. Rate of progression of chronic renal failure in predialysis patients treated with erythropoietin.
Abels R
Semin Nephrol; 1990 Mar; 10(2 Suppl 1):20-5. PubMed ID: 2192413
[No Abstract] [Full Text] [Related]
46. Epoetin: human recombinant erythropoietin.
Flaharty KK; Grimm AM; Vlasses PH
Clin Pharm; 1989 Nov; 8(11):769-82. PubMed ID: 2680241
[TBL] [Abstract][Full Text] [Related]
47. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
Romero González R; Torquet Escuder P
Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
[No Abstract] [Full Text] [Related]
48. [Pharmacokinetics and clinical effect of recombinant human erythropoietin on the anemia of predialysis patients].
Yamazaki C; Itoh A; Yamamoto N; Kobayashi M; Watanabe Y; Sakamoto N
Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):701-10. PubMed ID: 1479710
[TBL] [Abstract][Full Text] [Related]
49. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients.
Delano BG
Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):14-8. PubMed ID: 2757025
[TBL] [Abstract][Full Text] [Related]
50. In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells.
Ganser A; Bergmann M; Völkers B; Grützmacher P; Scigalla P; Hoelzer D
Exp Hematol; 1989 Jun; 17(5):433-5. PubMed ID: 2714423
[TBL] [Abstract][Full Text] [Related]
51. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
[TBL] [Abstract][Full Text] [Related]
52. Erythropoietin.
Beresford CH
N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007
[No Abstract] [Full Text] [Related]
53. Erythropoietin therapy in cancer patients.
Doweiko JP; Goldberg MA
Oncology (Williston Park); 1991 Aug; 5(8):31-7; discussion 38, 43-4. PubMed ID: 1834151
[TBL] [Abstract][Full Text] [Related]
54. [The effect of recombinant human erythropoietin on thrombocyte aggregation capacity and on the blood prostanoid level in patients with chronic kidney failure on hemodialysis].
Rud'ko IA; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
Ter Arkh; 1991; 63(10):128-30. PubMed ID: 1805410
[TBL] [Abstract][Full Text] [Related]
55. Erythropoietin and chronic renal failure.
Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Zingraff J; Delons S; Kreis H; Varet B
Nouv Rev Fr Hematol (1978); 1989; 31(2):97-8. PubMed ID: 2771635
[No Abstract] [Full Text] [Related]
56. Erythropoietin and renal anemia.
Hörl WH
Biotechnol Ther; 1991; 2(3-4):213-30. PubMed ID: 1845127
[TBL] [Abstract][Full Text] [Related]
57. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].
Stutz B; Rhyner K; Vögtli J; Binswanger U
Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079
[TBL] [Abstract][Full Text] [Related]
58. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment.
Sachs G; Siems W; Grune T; Schmidt G; Gerber G; Zoellner K
Biomed Biochim Acta; 1990; 49(2-3):S123-4. PubMed ID: 2386496
[TBL] [Abstract][Full Text] [Related]
59. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
[TBL] [Abstract][Full Text] [Related]
60. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
Fujita Y; Inoue S; Horiguchi S; Kuki A
Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]